Please assess the completion status of the following clinical trial:

Trial Title: Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Non Cystic Fibrosis Bronchiectasis~* Amount of secretion sufficient for analysis~* Capable of fulfilling the experimental protocol~Exclusion Criteria:~* Acute pulmonary disease~* Presence of any respiratory infection in the last four weeks

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Flutter group (Type: ACTIVE_COMPARATOR): In Flutter group the exercise used the Flutter ®VRP1 (VarioRaw SA, Switzerland).
- PEP group (Type: ACTIVE_COMPARATOR): In PEP group the exercise used the Flutter ®VRP1 (VarioRaw SA, Switzerland) without the steel ball inside, with the closure of so many holes as necessary to produce a positive expiratory pressure equivalent to pressure achieved by patients during the performance with the ball in the Flutter®VRP1.
- control group (Type: PLACEBO_COMPARATOR): In placebo patients were assessed as pulmonary function, respiratory muscle strength and transport properties of respiratory secretions
- Group Sham (Type: SHAM_COMPARATOR): Exercise with Flutter®VRP1 without the ball inside

Based on this trial design, predict the completion outcome and termination type (if applicable).